Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
Date:10/26/2010

tely 46%.

The increase in gross margins, excluding the items noted above, can primarily be attributed to both Generics, mainly the North America region, and Specialty.  In North America, favorable gross margins were primarily the result of new product introductions, while Specialty benefitted from favorable pricing, mainly on the EpiPen® Auto-injector.  

Earnings from operations were $234.3 million for the three months ended September 30, 2010, compared to $61.3 million for the same prior year period.  Excluding the impact of purchase accounting related items in both periods, as mentioned above, as well as charges for litigation settlements, net, of $1.5 million and $114.3 million for the current and prior year quarters, earnings from operations increased to $310.3 million in the current quarter from $247.4 million in the prior year quarter.  The increase in operating income was driven by higher sales and gross profit as discussed above, partially offset by an increase in selling, general and administrative expenses (SG&A), primarily due to transaction costs related to the acquisition of Bioniche Pharma.  

Interest expense for the three months ended September 2010, totaled $87.5 million, compared to $77.0 million for the three months ended September 30, 2009.  The increase is primarily due to interest associated with the debt offerings in the second and third quarters of 2010, partially offset by lower overall debt balances on our Senior Credit Facility.   Included in interest expense for the current quarter and the comparable prior year period are $17.6 million and $10.8 million, primarily consisting of accretion of the discounts on our convertible debt instruments.

Other (expense) income, net, was expense of $15.3 million in the current quarter compared to income of $0.2 million in the comparable prior year period. Generally included in other (expense) income, net, are interest and divide
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Mylan Declares Quarterly Preferred Stock Dividend
2. Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
3. Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®
4. Delcath Signs Agreement With Synerx and Mylans Bioniche Teoranta for Melphalan Supply
5. Mylan Receives Approval for Fludarabine Phosphate Injection, USP
6. Mylan Launches Generic Version of Wellbutrin XL® Tablets
7. Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
8. Mylan Receives Approval for Generic Version of Prograf® Capsules
9. Mylan Completes Acquisition of Bioniche Pharma Sooner Than Expected
10. Mylan Announces Completion of Add-On Offering of Senior Notes
11. Mylan Announces Pricing of Add-On Offering of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... England and PITTSBURGH ... MYL ) today announced that its shareholders ... plc (NYSE: PRGO ; TASE) and the ... shareholders at an extraordinary general meeting of shareholders ... the votes cast at the extraordinary general meeting. ...
(Date:8/28/2015)... ANDOVER, Massachusetts y LONDRES, 28 de ... PHG, AEX: PHIA) anunció hoy su participación en ... donde exhibirá sus soluciones cardiológicas más recientes y ... IntelliSpace Cardiovascular, que conectan a las personas y ... forma de ayudar a diagnosticar, guiar los tratamientos ...
(Date:8/27/2015)...  The Academy of Managed Care Pharmacy (AMCP) ... draft guidance and proposed rule that calls for ... a nonproprietary name with an FDA-designated suffix. For ... from the FDA on the naming issue and ... the agency to use the same nonproprietary names ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... Negotiating an ... — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/importholdcrisis , US authorities are ... holding products, and imports from India. , With alerts on an uptick and a ...
(Date:8/30/2015)... ... August 30, 2015 , ... ... announce that Partner Daniel M. Kotin was recently elected to membership in the ... the highest degree of peer recognition and outstanding professionalism. , ABOTA is ...
(Date:8/30/2015)... ... August 30, 2015 , ... InHealth Media ( http://www.inhealthmedia.com ... Global Communications Director for InHealth Media. Mr. Spector comes with a wide ... years doing on-air television, producing shows, on air-radio and media relations. , ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional ... from Administrative assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products ... focused on your goals. Kathleen graduated from Florida State University with a ...
(Date:8/29/2015)... ... August 30, 2015 , ... ... — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent , The simple ... digital handwritten signature. , Clinical trial sites can now use audio, ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3Health News:InHealth Media Appoints New Global Communications Director 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4
... getting some extra sleep before a big game could ... ,Researcher Cheri Mah and colleagues at Stanford University observed ... ,They were told to maintain their usual sleeping habits ... they were instructed to get as much extra sleep ...
... single act of unprotected sex with an infected partner, adolescent ... chance of getting genital herpes . ,Britain is facing ... in sexually transmitted infections (STIs) and high levels of teenage ... doubt" alcohol and drugs enhance sexual activity, Independent Advisory Group ...
... India is still humming and hawing over the legislation aimed ... and in education. ,Union Health Minister Anbumani ... the Government was still holding talks with the NGOs on ... to the millions of infected. ,The bill ...
... Researchers at the Salk Institute for Biological Studies have found ... kind humans experience in everyday life, may contribute to ... a hallmark of Alzheimers disease. ,The researchers say ... Alzheimers disease, a number of studies have pointed to stress ...
... of HIV have been identified by Yale School of ... genome sequencing technology that quickly detects rare viral mutations. ... and senior author of the retrospective study that used ... today at the 16th International HIV Drug Resistance Workshop ...
... patients with rheumatoid arthritis (RA) is significantly reduced during ... trimester to the third trimester of the participants pregnancy ... ,This is the first prospective study to ... female RA patients throughout their pregnancy and at 6, ...
Cached Medicine News:Health News:UK Facing Major Sexual Health Crisis Among Teens 2Health News:UK Facing Major Sexual Health Crisis Among Teens 3Health News:Bill on HIV/AIDS Delayed Further 2Health News:Emotional Stress Could Be a Factor in Causing Alzheimers: Study 2Health News:HIV Drug Resistance can Be Identified by Genome Sequencing 2Health News:Intensity of Rheumatoid Arthritis Significantly Reduced by Pregnancy 2
B-Hemoglobin test system provide quick, simple and reliable quantitative hemoglobin results. It has unbreakable, disposable cuvette which collect the exact amount of blood and mixes the sample with t...
... System: The D-10 Hemoglobin Testing System ... It provides a fully automated system which ... a single platform. Programs for rapid HbA1c ... away and can be easily integrated into ...
... The ADVIA 120 Hematology System gets ... right the first time, with a ... systems. Results are more accurate, physicians ... more effective. The ADVIA 120 Hematology ...
... The Sysmex XE-2100 provides users with the ... for advanced patient diagnosis and therapeutic monitoring. ... cytometry and advanced cell-counting methods, the XE-2100 ... differential that includes automatic enumeration of NRBC, ...
Medicine Products: